FORTAZ IN PLASTIC CONTAINER (nda050634)- (EQ 10MG BASE/ML,EQ 20MG BASE/ML,EQ 40MG BASE/ML)

Generic Name	CEFTAZIDIME SODIUM	Innovator	PAI HOLDINGS PHARM
Dosage	EQ 10MG BASE/ML,EQ 20MG BASE/ML,EQ 40MG BASE/ML
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	FORTAZ is indicated for the treatment of patients with infections: 1. Lower Respiratory Tract Infections 2. Skin and Skin-Structure Infections 3. Urinary Tract Infections 4. Bacterial Septicemia 5. Bone and Joint Infections 6. Gynecologic Infections 7. Intra-abdominal Infections 8. Central Nervous System Infections.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 10MG BASE/ML	**	**	-	-	-
EQ 20MG BASE/ML	**	**	-	-	-
EQ 40MG BASE/ML	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of FORTAZ IN PLASTIC CONTAINER